Liposomes as a drug carrier in the pharmaceutical industry has gained currency since its
discovery in 1965 by Bangham A. D. Liposomes have been shown to improve bioavailability
as they can be delivered to target sites ...

Tuberculosis is a communicable disease which affects millions of people around the world.
Although the case reports are declining, the eradication rate of this disease is far too slow.
Natural products have played a key ...

Nanoparticle drug delivery is challenged by the binding of proteins in
blood which result in their rapid removal from the circulatory system. Nanoparticles
engineered to delay protein binding have shown to have extended ...

Malaria poses devastating health and socioeconomic outcomes on global health especially
among pregnant women and children below the age of 5 in endemic areas. This is
exacerbated by Plasmodium falciparum resistance to ...

The rapid increase in access to new antiretrovirals (ARVs) worldwide and, especially in sub-Saharan Africa, coupled with the well-documented problem of poor quality ARVs in developing countries has underscored the need for ...